Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Magic Internet Math
Brian HIrschfield and Rob Hamilton
Talking Biotech with Dr. Kevin Folta
Kevin Folta
emDOCs.net Emergency Medicine (EM) Podcast
emDOCs.net EM Crew
The Birding Life Podcast Network
The Birding Life Podcast Network
Learning from Nature: The Biomimicry Podcast with Lily Urmann
Lily Urmann
The Climate Biotech Podcast
Homeworld Collective
Be Amazed
Be Amazed
Ciência
RFI Português
Forensic Psychology
Circle Of Insight Productions
Science News Daily
brief.news
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Pharmaceutical Executive
Pharmaceutical Executive Podcast
Goalie Science
Elite Goalie Method
The Dissenter
Ricardo Lopes
R2Kast - People in Food and Farming/All In
Wallace Currie
Today's Creation Moment
Creation Moments
Every Animal Ever
Dr Cesar Puechmarin, Zach Mander
Cuentos y Leyendas de Honduras
Cuentos y Leyendas de Honduras
A Ciencia Cierta
meteolp
Deutsche Creepypasta Stories
Sezgin
Brainforest Café
SpectreVision Radio
Retro Radio: Old Time Radio in the Dark
Darren Marlar
TED-Ed
TED-Ed
Alpha Male Podcast - Christian Strength & Masculinity
Michael Milito
Expreso de Medianoche (Oficial)
MEDIANOCHE Producciones
My Weird Prompts
Daniel Rosehill
Physio Edge podcast with David Pope
David Pope
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
The Why Files: Operation Podcast
The Why Files
The Evidence Based Rheumatology Podcast
Michael Putman
PBS Space Time
PBS
Uncommon Knowledge
Hoover Institution
The Mental Mastery Alliance
The Team
The Science Pawdcast
Jason and Kris Zackowski
Plants, People, Science
American Society for Horticultural Science (ASHS)
Galactic Horrors
Galactic Horrors
Science
Michael Putman
Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a "maybe less efficacious maybe less toxic" pathway. I could see folks being excited for this, especially in a disease where non...
Big trial this week in the NEJM investigating the IL17 inhibitor secukinumab in PMR. Well worth a read, I would bet on FDA approval in the near future. Some interesting tidbits and of course a weird safety thing we now h...
Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzepatide to ixekizumab alone. Raises some interesting questions about what worked here and whether or not it matters h...
Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option. Study: https:...
Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece! Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa25...
Quick podcast this week about a nifty head to head study that I had previously missed. Worth reading if - like me - you're still trying to figure out how the heck to manage osteoporosis. Paper: https://pubmed.ncbi.nlm.n...
Today I cover the recent publication of the RESET-RA study, which evaluated vagal nerve stimulation to treat rheumatoid arthritis. Have a listen in full, but let me be clear upfront: I do not think this works and will no...
Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one. Paper: https://www.nej...
Ever wonder how often you really need to check "monitoring" labs? If so then this is the podcast for you! Bryant England mentioned this during his excellent Year in Review session at ACR Convergence 2025. I've been meani...
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been...
Another episode looking into safety this week! Tackling that pesky issue of TNFs and CHF. Be sure to subscribe to my newsletter and check out the papers below! Newsletter: https://sprw.io/stt-ee87b4 ATTACH: https://pu...
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me abou...
Interesting read this week - I cover a nifty little paper that presented data about adrenal insufficiency after stopping prednisolone, published in JAMA Open in March 2025. Open Access Journal Here: https://jamanetwo...
Interesting NEJM trial this week comparing methotrexate to prednisone for pulmonary sarcoidosis. Paper available here: https://www.nejm.org/doi/full/10.1056/NEJMoa2501443
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting to...
This week I cover another of my newsletters, though I mostly use it as a skeleton to riff on a common (and challenging) issue for rheumatology consultants; diagnosing HLH. Check out the guidelines themselves here and hav...
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found her...
What do you do when observational data and RCTs conflict? This week I'm covering the "real world PEXIVAS" study that was done by the French Vasculitis Study Group. Great read, interesting issues, have a listen and be sur...
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell deple...
Podcast this week about overdiagnosis! Currently one of my favorite topics and something that I think will be an emerging issue in our field. We recently published a Viewpoint in Lancet Rheumatology (https://pubmed.ncbi....
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.